Celsite Implantable Access Port System
Recall Z-2382-2015, part of FDA recall event 71666. See B. Braun Interventional Systems's company page.
B. Braun Interventional Systems started this Class II device recall on Jun 16, 2015 (voluntary: firm initiated); FDA lists it as terminated, terminated Nov 20, 2015.
- Classification: Class II
- Started: Jun 16, 2015
- Status: Terminated
The manufacturer, B. Braun medical France, received endotoxin test results that are out of specification for the peelable sheath (A1537).
- Product
- Celsite Implantable Access Port System, model ST301. The Celsite Implantable Access Port Systems (Celsite port systems) are implantable port and catheter systems that allow safe, repeated access to the patient's bloodstream. The port chamber and catheter design can be used for the administration of medication and fluids. The Celsite system consists of an access port with a silicone septum, which is connected to a catheter using a connection ring. The triangular shaped access port has a low profile nose, finger stops on the side of the housing, and a round base. Celsite access ports have suture holes or suture zones to secure placement during implantation.
- Quantity
- 11 units
- Lots and codes
- Lot number: 36896615
- Distribution
- CA and NY only.
- Recalling firm
- B. Braun Interventional Systems, Minneapolis, MN, United States
- How the firm notified
- Letter
- FDA classified
- Aug 13, 2015
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports